Home FNO Stocks Apollo Hospitals Enterprise – Detailed Fundamental Screener & Price Target

Apollo Hospitals Enterprise – Detailed Fundamental Screener & Price Target

31
0
apoolo pharmacy

Investment View: Bullish (Long-Term Compounder)

Apollo Hospitals remains one of India’s highest-quality healthcare businesses with leadership across hospitals, diagnostics, pharmacies, and digital healthcare. The company’s expansion strategy, improving profitability, and rising demand for specialty healthcare continue to support long-term earnings growth. FY26 revenue grew 16% while net profit increased 34%, supported by higher occupancy, better case mix, and digital business improvements.


Fundamental Screener

Parameter Analysis Rating
Business Quality Market leader in healthcare ⭐⭐⭐⭐⭐
Revenue Growth Strong double-digit growth ⭐⭐⭐⭐⭐
Profit Growth Excellent ⭐⭐⭐⭐⭐
ROE Healthy and improving ⭐⭐⭐⭐☆
ROCE Strong capital efficiency ⭐⭐⭐⭐☆
Operating Margin Consistently expanding ⭐⭐⭐⭐⭐
Debt Comfortable for expansion ⭐⭐⭐⭐☆
Cash Flow Strong operating cash generation ⭐⭐⭐⭐⭐
Promoter Quality Excellent management ⭐⭐⭐⭐⭐
Institutional Holding Very High ⭐⭐⭐⭐⭐
Competitive Advantage Wide economic moat ⭐⭐⭐⭐⭐

Overall Fundamental Score: 9.6/10


Business Segments

🏥 Hospitals

  • Largest contributor to profits
  • Premium tertiary and quaternary healthcare
  • High-margin specialties:
    • Cardiology
    • Oncology
    • Neurology
    • Organ Transplants
    • Orthopedics

💊 Apollo Pharmacy

  • India’s largest pharmacy network
  • Growing omnichannel presence
  • Increasing profitability

🧪 Diagnostics

  • Expanding laboratory network
  • Higher operating leverage
  • Cross-selling opportunities

📱 Apollo 24/7

  • Digital consultations
  • Medicine delivery
  • Online diagnostics
  • Expected to become a meaningful profit driver over time

Growth Drivers (Option Traders View)

Option Traders Must watch These Stocks to Buying Options . Movement in Healthcare Sector To Confirm The Trend .In Same Sector and Movement to watch The FNO Stocks in healthcare 

  • Apollo Hospitals
  • Fortis Healthcare 
  • Max healthcare institute  

 

1. Massive Bed Expansion

Apollo plans to significantly increase hospital capacity over the coming years, supporting long-term revenue growth. Reuters also reported the company expects mid-to-high teen revenue growth supported by specialty care demand and expansion.


2. Rising Healthcare Demand

Drivers include:

  • Aging population
  • Lifestyle diseases
  • Higher insurance penetration
  • Medical tourism
  • Increasing income levels

These create a long runway for premium healthcare providers.


3. Premium Specialties

High-value procedures continue to grow faster than general healthcare:

  • Oncology
  • Cardiac Sciences
  • Neurosciences
  • Organ Transplants

These specialties improve margins and average revenue per patient.


4. Digital Healthcare

Apollo 24/7 is improving profitability through:

  • Online consultations
  • Digital pharmacy
  • Health subscriptions
  • Better patient retention

5. Strong Brand

Apollo remains one of India’s most trusted hospital brands, giving it pricing power and high patient loyalty.


Strengths

✅ Market leader

✅ Premium pricing power

✅ Strong cash generation

✅ Multiple revenue streams

✅ Excellent management

✅ Long growth runway

✅ High institutional confidence


Risks

  • High valuation compared with the broader market
  • Execution risk in large hospital expansions
  • Competition from premium hospital chains
  • Regulatory changes affecting healthcare pricing
  • Initial pressure on margins from newly commissioned hospitals until occupancy improves.

Technical Outlook

Trend: Strong Bullish

  • Higher highs and higher lows
  • Strong institutional buying
  • Long-term moving averages remain supportive
  • Suitable for accumulation on corrections rather than chasing sharp rallies

Earnings Outlook

Analysts expect growth to be driven by:

  • Higher occupancy
  • Improved realization per bed
  • Margin expansion
  • Better contribution from digital and pharmacy businesses
  • Continued hospital capacity additions.

Price Target

Time Period Target
12 Months ₹9,000–9,300
2 Years ₹10,500–11,500
3–5 Years ₹14,000–16,500
2030 (Bull Case) ₹18,000–22,000

These are scenario-based estimates derived from expected earnings growth, expansion plans, and valuation assumptions—not guaranteed future prices.

apollo


Suitable For

  • ✅ Long-term investors
  • ✅ SIP investors
  • ✅ Portfolio core holding
  • ✅ Healthcare sector allocation
  • ✅ Moderate-risk investors

LEAVE A REPLY

Please enter your comment!
Please enter your name here